You are here

Developing a highly specific and sensitive glucagon ELISA kit

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DK106946-01
Agency Tracking Number: R43DK106946
Amount: $224,670.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: 200
Solicitation Number: DK14-008
Timeline
Solicitation Year: 2015
Award Year: 2015
Award Start Date (Proposal Award Date): 2015-09-01
Award End Date (Contract End Date): 2016-08-31
Small Business Information
10151 Pacific Mesa Blvd.
San Diego, CA 92121-4329
United States
DUNS: 186489899
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 XIAOMIN FAN
 (858) 768-8107
 xfan@avantgen.com
Business Contact
 CATHERINE CATHERINE WOODS
Phone: (858) 775-7033
Email: cmwoods@avantgen.com
Research Institution
N/A
Abstract

DESCRIPTION provided by applicant With prediabetes and diabetes reaching epidemic proportions there is an urgent need to identify more effective therapeutics Diabetes is characterized by elevated levels of the peptide hormone glucagon and inappropriate suppression of glucagon during an oral glucose tolerance test Glucagon plays a major role in up regulating glucose release from the liver during hypoglycemic conditions and serves as a key counter regulatory hormone to insulin Consequently glucagon pathways are an attractive target for therapeutic intervention However tissue specific processing of the proglucagon precursor results in the production of several other peptide hormones such as oxyntomodulin GLP and GLP that also affect glucose levels but by different direct or indirect modes of action The presence of several alternatively cleaved products that also harbor the glucagon sequence along with the low levels andlt pM of glucagon in the circulation has hampered efforts to develop a suitable assay for accurate determination of glucagon levels when analyzing potential therapeutic targets The goal of this proposal is to use AvantGenandapos s novel yeast display system and rabbit monoclonal antibody discovery technology to isolate pM affinity highly specific anti glucagon antibody clones to be used to develop a highly specific and sensitive assay reagents

PUBLIC HEALTH RELEVANCE The peptide hormone glucagon plays a key counter regulatory role to insulin in regulating glucose levels in the circulation It is produced from a larger precursor in the pancreas in response to low glucose levels However tissue specific cleavage of the glucagon precursor results in many different peptides each exerting different effects on the regulation of glucose blood levels Consequently targeting this system has therapeutic value for diabetes However a thorough understanding of the biology of glucagon has been limited by the availability of assays that can accurately monitor glucagon hormone levels In this proposal we plan to address this need by using AvantGenandapos s novel antibody discovery technology to isolate high affinity highly specific antibodies for glucagon and use them to develop a suitable assay for accurate determination of glucagon in the circulation

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government